About Proteacel

About company

Proteacel is creating a new standard for gene transfection. The company’s core patented technology is Perforation Optimization and Repair Enhancement (PORE™), a non-viral gene delivery product licensed exclusively and worldwide to Proteacel. PORE™ demonstrates a superior methodology by surpassing the current industry standards for gene delivery and cell viability, the two most pivotal outcomes of the transfection process. The PORE™ technology is scalable, allows for complex transfections and maintains long-term growth potential of genetically modified cells.